Better adherence to bisphosphonate therapy is associated with reduced nonvertebral fracture risk

被引：0
|
作者：
Sunyecz, John A. [1 ]
Bachmann, Gloria [1 ]
Barr, Charles E. [1 ]
Silverman, Stuart [1 ]
机构：
[1] Laurel Highlands Ob Gyn, PC, Hopwood, PA USA
来源：
OBSTETRICS AND GYNECOLOGY | 2006年 / 107卷 / 04期
关键词：
D O I：
10.1097/00006250-200604001-00057
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：25S / 25S
页数：1
相关论文
共 50 条
  • [11] Atypical fracture with long-term bisphosphonate therapy is associated with altered cortical composition and reduced fracture resistance
    Lloyd, Ashley A.
    Gludovatz, Bernd
    Riedel, Christoph
    Luengo, Emma A.
    Saiyed, Rehan
    Marty, Eric
    Lorich, Dean G.
    Lane, Joseph M.
    Ritchie, Robert O.
    Busse, Bjoern
    Donnelly, Eve
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (33) : 8722 - 8727
  • [12] Nonvertebral fracture risk is significantly reduced with risedronate treatment in just one year
    Olszynski, W
    Adachi, JD
    Brown, J
    JOURNAL OF RHEUMATOLOGY, 2003, 30 (08) : 1886 - 1886
  • [13] Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: Reduction in risk of nonvertebral fracture is not related to change in BMD
    Watts, NB
    Geusens, P
    Barton, IP
    Felsenberg, D
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (12) : 2097 - 2104
  • [14] Clinical and nonvertebral fracture risk is reduced with the use of ibandronate in women with postmenopausal osteoporosis
    Miller, P. D.
    Harris, S. T.
    Blumentals, W. A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S451 - S451
  • [15] Medication adherence and fracture risk among patients on bisphosphonate therapy in a large United States health plan
    Wade, Sally W.
    Curtis, Jeffrey R.
    Yu, Jingbo
    White, Jeffrey
    Stolshek, Bradley S.
    Merinar, Claire
    Balasubramanian, Akhila
    Kallich, Joel D.
    Adams, John L.
    Viswanathan, Hema N.
    BONE, 2012, 50 (04) : 870 - 875
  • [16] Duration of Bisphosphonate Drug Holidays and Associated Fracture Risk
    Curtis, Jeffrey R.
    Saag, Kenneth G.
    Arora, Tarun
    Wright, Nicole C.
    Yun, Huifeng
    Daigle, Shanette
    Matthews, Robert
    Delzell, Elizabeth
    MEDICAL CARE, 2020, 58 (05) : 419 - 426
  • [17] INCREASED PROTECTION FROM NONVERTEBRAL FRACTURE ASSOCIATED WITH LONGER DURATION OF TERIPARATIDE THERAPY
    Pohl, G.
    Wang, J.
    Eriksen, E. F.
    CALCIFIED TISSUE INTERNATIONAL, 2004, 74 : S97 - S97
  • [18] Adherence to bisphosphonates (BPs) is associated with reduced fracture risk in women with postmenopausal osteoporosis (PMO)
    Siris, E
    Harris, S
    Silverman, S
    Abbott, T
    Barr, C
    Rosen, C
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2005, 12 (06): : 807 - 807
  • [19] Adherence to bisphosphonate therapy for osteoporosis
    Nature Clinical Practice Rheumatology, 2007, 3 (2): : 66 - 66
  • [20] Adherence to Oral Bisphosphonate Therapy in a Fracture Liaison Service: A Randomised Controlled Trial
    Ganda, Kirtan
    Seibel, Markus
    Schaffer, Andrea
    Pearson, Sallie
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
12345